Coronavirus - What will the impact be?
With the number of confirmed deaths increasing everyday, what impact will the Coronavirus have?
12 Total results for product and free and sample content found
Scrip
By Brian Yang 30 Jan 2020
AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.
Medtech Insight
30 Jan 2020
The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.
Topic Drug approval Coronovirus FDA
Medtech Insight
By Sue Darcey 30 Jan 2020
A new coronavirus test template developed by the US Centers for Disease Control and Prevention is being refined by the agency so it can be shared with domestic and international partners to help identify more cases of the virus. In the meantime, state labs can use the posted assay for coronavirus on the CDC’s website for testing of residents within their jurisdiction and send results to the CDC.
Scrip
By Andrew McConaghie 30 Jan 2020
The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.
Topic Coronovirus Vaccines
Scrip
By Andrew McConaghie 30 Jan 2020
As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.
Topic Coronovirus Research Vaccines
Scrip
By Andy Smith 30 Jan 2020
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.
Scrip
By Andrew McConaghie 30 Jan 2020
The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.
Topic Company Analysis Coronovirus Infectious Diseases Vaccines
Medtech Insight
By Sue Darcey 30 Jan 2020
Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.
Topic Drug approval Clinical Trials Coronovirus Policy and regulation
Medtech Insight
By Sue Darcey 30 Jan 2020
The US Food and Drug Administration (FDA) stands poised to proceed with hastened approvals for 2019-coronavirus (nCoV) diagnostics, treatments and vaccines, if a public health emergency is declared, after an infected US traveler who caught the disease in Wuhan, China returned from the province to Washington State. Spread of the disease has reached a crisis level in China, and the World Health Organization met on 22 and 23 January to consider what actions to take to contain the virus, while issuing an interim laboratory test guidance for use in diagnosing the disease.
Topic Drug approval Clinical Trials Coronovirus Policy and regulation
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: